This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Aug;13(4):259-61.

doi: 10.1007/s11906-011-0203-1.

To ACCELERATE hypertension control

Helmy M Siragy¹

Affiliations

PMID: 21494776
DOI: 10.1007/s11906-011-0203-1

Comment

To ACCELERATE hypertension control

Helmy M Siragy. Curr Hypertens Rep. 2011 Aug.

. 2011 Aug;13(4):259-61.

doi: 10.1007/s11906-011-0203-1.

Author

Helmy M Siragy¹

Affiliation

¹ Department of Medicine, University of Virginia Health Center, Charlottesville, VA 22908, USA. hms7a@virginia.edu

PMID: 21494776
DOI: 10.1007/s11906-011-0203-1

No abstract available

PubMed Disclaimer

Comment on

Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy for hypertension control (ACCELERATE): a randomised, parallel-group trial.
Brown MJ, McInnes GT, Papst CC, Zhang J, MacDonald TM. Brown MJ, et al. Lancet. 2011 Jan 22;377(9762):312-20. doi: 10.1016/S0140-6736(10)62003-X. Epub 2011 Jan 12. Lancet. 2011. PMID: 21236483 Clinical Trial.

References

1. JAMA. 2002 Dec 18;288(23):2981-97 - PubMed
1. Lancet. 2005 Sep 10-16;366(9489):895-906 - PubMed
1. Lancet. 2004 Jun 19;363(9426):2049-51 - PubMed
1. N Engl J Med. 2008 Dec 4;359(23):2417-28 - PubMed
1. Hypertension. 2003 Dec;42(6):1206-52 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Springer